GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Health & Life Co Ltd (ROCO:1781) » Definitions » Cyclically Adjusted Revenue per Share

Health & Life Co (ROCO:1781) Cyclically Adjusted Revenue per Share : NT$16.49 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Health & Life Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Health & Life Co's adjusted revenue per share for the three months ended in Dec. 2024 was NT$2.733. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$16.49 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Health & Life Co's average Cyclically Adjusted Revenue Growth Rate was 0.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -4.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Health & Life Co was -3.60% per year. The lowest was -4.90% per year. And the median was -4.00% per year.

As of today (2025-04-26), Health & Life Co's current stock price is NT$12.85. Health & Life Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was NT$16.49. Health & Life Co's Cyclically Adjusted PS Ratio of today is 0.78.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Health & Life Co was 2.72. The lowest was 0.32. And the median was 0.85.


Health & Life Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Health & Life Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health & Life Co Cyclically Adjusted Revenue per Share Chart

Health & Life Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.48 19.19 18.26 16.35 16.49

Health & Life Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.35 16.66 16.65 16.60 16.49

Competitive Comparison of Health & Life Co's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Health & Life Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health & Life Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Health & Life Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Health & Life Co's Cyclically Adjusted PS Ratio falls into.


;
;

Health & Life Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Health & Life Co's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=2.733/133.1571*133.1571
=2.733

Current CPI (Dec. 2024) = 133.1571.

Health & Life Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 3.448 99.621 4.609
201506 3.435 100.684 4.543
201509 5.221 100.392 6.925
201512 2.454 99.792 3.274
201603 1.831 100.470 2.427
201606 3.669 101.688 4.804
201609 4.521 101.861 5.910
201612 3.201 101.863 4.184
201703 2.790 102.862 3.612
201706 2.571 103.349 3.313
201709 3.150 104.136 4.028
201712 2.808 104.011 3.595
201803 1.878 105.290 2.375
201806 4.545 106.317 5.692
201809 4.043 106.507 5.055
201812 2.344 105.998 2.945
201903 2.233 107.251 2.772
201906 2.252 108.070 2.775
201909 2.405 108.329 2.956
201912 1.997 108.420 2.453
202003 2.228 108.902 2.724
202006 4.485 108.767 5.491
202009 4.890 109.815 5.929
202012 4.748 109.897 5.753
202103 4.459 111.754 5.313
202106 4.153 114.631 4.824
202109 3.698 115.734 4.255
202112 4.843 117.630 5.482
202203 3.101 121.301 3.404
202206 5.351 125.017 5.699
202209 4.975 125.227 5.290
202212 4.823 125.222 5.129
202303 2.747 127.348 2.872
202306 3.030 128.729 3.134
202309 4.526 129.860 4.641
202312 2.430 129.419 2.500
202403 4.259 131.776 4.304
202406 2.419 132.554 2.430
202409 4.748 133.029 4.753
202412 2.733 133.157 2.733

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Health & Life Co  (ROCO:1781) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Health & Life Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.85/16.49
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Health & Life Co was 2.72. The lowest was 0.32. And the median was 0.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Health & Life Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Health & Life Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Health & Life Co Business Description

Traded in Other Exchanges
N/A
Address
Jian 1st Road, 9th Floor, No-186, New Taipei City, TWN
Health & Life Co Ltd manufactures medical devices in the fields of cardiovascular disease and in-vitro diagnostics in Taiwan. Its product portfolio includes blood pressure monitor series, nebulizer, and blood glucose monitoring system, blood glucose stripes and Thermometer.

Health & Life Co Headlines

No Headlines